Relamorelin to Treat Constipation: “Pusher” or Pushover?
نویسندگان
چکیده
منابع مشابه
Distress: to treat or not to treat?
In one of our research group meetings, we took an informal poll to find out who would prescribe a benzodiazepine to someone who was acutely grieving, felt anxious, was experiencing some insomnia, and wanted relief from distress. The younger among us mostly would prescribe while those of us who are grizzled would mostly refrain from doing so. Coincidentally, within the next week, one of my patie...
متن کامل[Fever : to treat or not to treat ?]
Fever is routinely faced during medical practice. Although it is part of the immune response against pathogens, it is often seen as deleterious and a source of discomfort leading to the use of antipyretic drugs. However, few clinical data support this common practice. On the contrary, to date, results tilt in favor of the beneficial effect of fever, such as a better immune response and inhibiti...
متن کاملFuture Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists
There is an unmet need for effective pharmacological therapies for constipation, a symptom that significantly deteriorates patients' quality of life and impacts health care. Ghrelin is an endogenous ligand for the growth hormone secretagogue receptor and has been shown to exert prokinetic effects on gastrointestinal (GI) motility via the vagus and pelvic nerves. The pharmacological potential of...
متن کاملDialysis in the elderly, to treat or not to treat?
The population on renal replacement therapy (RRT) currency, but rather describes the approach to probhas become older and beset by more co-morbidity than lems by thinking citizens in a given society and, for was thought possible when dialysis was introduced. each of us, is influenced by our religious beliefs and About half of the stock is over the normal retirement by the different ethical cons...
متن کاملEarly-stage ovarian cancer: to treat or not to treat.
Approximately one-third of patients with epithelial ovarian cancer present with localized disease confined to the ovaries or pelvis (International Federation of Gynecology and Obstetrics [FIGO] stages I and II). Although their long-term prognosis is better (10-year survival 50%–70%) than that of patients with advanced ovarian cancer (10-year survival 15%–25%), approximately 50% of women with ea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Digestive Diseases and Sciences
سال: 2015
ISSN: 0163-2116,1573-2568
DOI: 10.1007/s10620-015-3929-9